HomeCompareCIVVX vs JNJ

CIVVX vs JNJ: Dividend Comparison 2026

CIVVX yields 10.32% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CIVVX wins by $19.5K in total portfolio value
10 years
CIVVX
CIVVX
● Live price
10.32%
Share price
$21.63
Annual div
$2.23
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.6K
Annual income
$1,972.39
Full CIVVX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CIVVX vs JNJ

📍 CIVVX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCIVVXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CIVVX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CIVVX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CIVVX
Annual income on $10K today (after 15% tax)
$877.18/yr
After 10yr DRIP, annual income (after tax)
$1,676.53/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CIVVX beats the other by $972.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CIVVX + JNJ for your $10,000?

CIVVX: 50%JNJ: 50%
100% JNJ50/50100% CIVVX
Portfolio after 10yr
$29.8K
Annual income
$1,400.09/yr
Blended yield
4.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CIVVX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CIVVX buys
0
JNJ buys
0
No recent congressional trades found for CIVVX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCIVVXJNJ
Forward yield10.32%3.36%
Annual dividend / share$2.23$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$39.6K$20.0K
Annual income after 10y$1,972.39$827.78
Total dividends collected$15.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CIVVX vs JNJ ($10,000, DRIP)

YearCIVVX PortfolioCIVVX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,732$1,031.98$10,676$355.77+$1.1KCIVVX
2$13,685$1,131.51$11,407$389.39+$2.3KCIVVX
3$15,876$1,233.50$12,198$426.53+$3.7KCIVVX
4$18,325$1,337.41$13,056$467.62+$5.3KCIVVX
5$21,050$1,442.70$13,987$513.12+$7.1KCIVVX
6$24,073$1,548.86$14,998$563.56+$9.1KCIVVX
7$27,413$1,655.36$16,098$619.52+$11.3KCIVVX
8$31,094$1,761.75$17,295$681.69+$13.8KCIVVX
9$35,138$1,867.56$18,599$750.82+$16.5KCIVVX
10$39,570$1,972.39$20,022$827.78+$19.5KCIVVX

CIVVX vs JNJ: Complete Analysis 2026

CIVVXStock

The fund invests primarily in common stocks of companies in developed countries outside the U.S. Normally, it invests at least 80% of its total assets in stocks of companies in a number of foreign countries and invests the majority of its total assets in companies that pay dividends or repurchase their shares. The fund may invest up to 15% of its total assets in companies in emerging (less developed) markets.

Full CIVVX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CIVVX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CIVVX vs SCHDCIVVX vs JEPICIVVX vs OCIVVX vs KOCIVVX vs MAINCIVVX vs ABBVCIVVX vs MRKCIVVX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.